[Introducing mibefradil--a new T-calcium channel blocker].
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D004110:Diltiazem / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D020748:Mibefradil; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use; D013764:Tetrahydronaphthalenes / Q000494:pharmacology / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil; D004110:Diltiazem; D009543:Nifedipine